Literature DB >> 11594412

Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood.

D Iarussi1, M Galderisi, G Ratti, M A Tedesco, P Indolfi, F Casale, M T Di Tullio, O de Divitiis, A Iacono.   

Abstract

BACKGROUND: In childhood, late cardiotoxicity is characterized by inappropriately thin wall and consequent increased end-systolic wall stress, but the associations of impaired left ventricular geometry and function occurring under these circumstances need further investigation. HYPOTHESIS: The purpose of this study was to assess anthracycline late effects on the relationships occurring between increased end-systolic stress (ESS) and changes in both M-mode systolic measurements (i.e., endocardial and midwall fractional shortening) and Doppler diastolic indices in the pediatric age.
METHODS: The population consisted of 101 children treated with anthracyclines for at least 12 months and 91 healthy children. Using M-mode echocardiography, end-systolic wall stress was calculated as index of afterload, and endocardial and midwall fractional shortening as systolic indices. Doppler transmitral measurements were made as diastolic indices.
RESULTS: Patients treated with anthracyclines showed significantly lower relative wall thickness and left ventricular mass index, greater end-systolic wall stress, reduced endocardial and midwall fractional shortening and peak E/A ratio, prolonged deceleration, and isovolumic relaxation times. Direct relationships were found between end-systolic wall stress and both endocardial and midwall shortening. The use of midwall shortening in the relation showed a greater, but not significant increase (from 3 to 6%) in the proportion of patients with depressed systolic function than did endocardial shortening. In the anthracycline group, end-systolic wall stress was also inversely related to relative wall thickness and directly to isovolumic relaxation time.
CONCLUSIONS: In childhood, reduced myocardial thickness and increased afterload explain much of systolic and diastolic dysfunction of late anthracycline toxicity. Midwall fractional shortening does not seem to add useful information for identifying subsets of children more prone to the development of heart failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594412      PMCID: PMC6655021          DOI: 10.1002/clc.4960241006

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  13 in total

1.  Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.

Authors:  Lubomir Elbl; Hana Hrstkova; Iva Tomaskova; Bohumir Blazek; Jaroslav Michalek
Journal:  Eur J Pediatr       Date:  2005-07-26       Impact factor: 3.183

Review 2.  Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.

Authors:  Diana Iarussi; Paolo Indolfi; Fiorina Casale; Vincenzo Martino; Maria Teresa Di Tullio; Raffaele Calabrò
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.

Authors:  Lubomir Elbl; Hana Hrstkova; Iva Tomaskova; Jaroslav Michalek
Journal:  Support Care Cancer       Date:  2005-07-21       Impact factor: 3.603

4.  Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.

Authors:  Jennifer H Jordan; Sujethra Vasu; Timothy M Morgan; Ralph B D'Agostino; Giselle C Meléndez; Craig A Hamilton; Andrew E Arai; Songtao Liu; Chia-Ying Liu; João A C Lima; David A Bluemke; Gregory L Burke; W Gregory Hundley
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792

5.  Left Ventricular Mass Change After Anthracycline Chemotherapy.

Authors:  Jennifer H Jordan; Sharon M Castellino; Giselle C Meléndez; Heidi D Klepin; Leslie R Ellis; Zanetta Lamar; Sujethra Vasu; Dalane W Kitzman; William O Ntim; Peter H Brubaker; Nathaniel Reichek; Ralph B D'Agostino; W Gregory Hundley
Journal:  Circ Heart Fail       Date:  2018-07       Impact factor: 8.790

6.  The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer.

Authors:  Lubomir Elbl; Hana Hrstkova; Vaclav Chaloupka
Journal:  Eur J Pediatr       Date:  2003-08-07       Impact factor: 3.183

7.  Strain echocardiography in early detection of Doxorubicin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.

Authors:  Mohammed Al-Biltagi; Osama Abd Rab Elrasoul Tolba; Mohammed Ramadan El-Shanshory; Nagla Abd El-Aziz El-Shitany; Eslam El-Sayed El-Hawary
Journal:  ISRN Pediatr       Date:  2012-01-24

Review 8.  MRI of Cardiotoxicity.

Authors:  Jennifer Hawthorne Jordan; William Gregory Hundley
Journal:  Cardiol Clin       Date:  2019-08-31       Impact factor: 2.410

Review 9.  Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity.

Authors:  De-Shu Chen; Jing Yan; Ping-Zhen Yang
Journal:  Front Cardiovasc Med       Date:  2022-02-25

Review 10.  Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

Authors:  Maurizio Galderisi; Francesco Marra; Roberta Esposito; Vincenzo Schiano Lomoriello; Moira Pardo; Oreste de Divitiis
Journal:  Cardiovasc Ultrasound       Date:  2007-01-25       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.